Role of Conservative Management in Emphysematous Pyelonephritis - A Retrospective Study.

INTRODUCTION Emphysematous pyelophritis (EPN) is a serious condition with significant mortality. The prognosis of patients with EPN has changed over the years. Mortality has declined with prompt and aggressive medical management and minimally invasive strategies. AIM To identify the prognostic factors and assess the outcome of conservative management of emphysematous pyelonephritis. SETTINGS AND DESIGN This was a retrospective study of 8 consecutive patients who were diagnosed with EPN in two medical institutes between July 2010 and June 2015. MATERIALS AND METHODS Eight consecutive patients diagnosed with emphysematous pyelonephritis between July 2010 and June 2015 was studied retrospectively. On the basis of Computerised tomographic scan findings they were grouped into four classes (1 to 4) according the modified classification recommended by Huang and Tseng. The management was conservative (combination of percutaneous drainage and antibiotics), immediate nephrectomy or delayed nephrectomy (when conservative management failed). Demographic, clinical, biochemical and radiological characteristics were assessed and compared between survivors and nonsurvivors. RESULTS Seven (87.5%) of a total of 8 patients had diabetes mellitus. Escherichia coli (71.4 %) was the most common offending pathogen identified in pus culture. With conservative management in 7 patients (combination of percutaneous drainage and antibiotics), treatment was successful in 57.14 % and with immediate nephrectomy (one patient), the success rate was 100%. The risk factors for mortality were thrombocytopenia, shock and altered sensorium at presentation. The mortality rate in class 1, 2 and 3 was 0%, 33.3% and 66.7%. None of the patient had class 4 EPN. CONCLUSION A combination of percutaneous drainage with antibiotics offers an effective therapy for emphysematous pyelonephritis.

[1]  C. Chao,et al.  Emphysematous pyelonephritis. , 2012, The American journal of the medical sciences.

[2]  T. Turunç,et al.  Tailored Treatment Approach for Emphysematous Pyelonephritis , 2011, Urologia Internationalis.

[3]  R. Kapoor,et al.  Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis , 2010, BJU international.

[4]  N. Kekre,et al.  Emphysematous pyelonephritis: outcome of conservative management. , 2008, Urology.

[5]  J. Wu,et al.  Host and bacterial virulence factors predisposing to emphysematous pyelonephritis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  S. Wann,et al.  Clinical characteristics of emphysematous pyelonephritis. , 2001, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[7]  C. Tseng,et al.  Emphysematous Pyelonephritis Clinicoradiological Classification, Management, Prognosis, and Pathogenesis , 2002 .

[8]  M. Bullard,et al.  Predictors of outcome in emphysematous pyelonephritis. , 1998, The Journal of urology.

[9]  T. El-Diasty,et al.  Emphysematous pyelonephritis: a 15-year experience with 20 cases. , 1997, Urology.

[10]  陳明潭,et al.  Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience , 1997 .

[11]  M. Bullard,et al.  Acute gas-producing bacterial renal infection: correlation between imaging findings and clinical outcome. , 1996, Radiology.

[12]  T. Ahlering,et al.  Emphysematous pyelonephritis: a 5-year experience with 13 patients. , 1985, The Journal of urology.

[13]  Date of Acceptance , 2022 .